CIC
IMGN

Cornercap Investment Counsel’s Immunogen Inc IMGN Stock Holding History

Cornercap Investment Counsel’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-53,313
Closed -$205K – 691
2023
Q1 		$205K Buy
53,313
+17,246
+48% +$73.5K 0.04% 503
2022
Q4 		$179K Buy
36,067
+234
+0.7% +$1.27K 0.03% 518
2022
Q3 		$171K Buy
35,833
+82
+0.2% +$432 0.03% 506
2022
Q2 		$161K Buy
+35,751
New +$155K 0.03% 498

Other funds holding IMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cornercap Investment Counsel's IMGN Position: Q2 2023 in Review

Cornercap Investment Counsel sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 53,313 shares — an estimated $205K sold.

Cornercap Investment Counsel first reported a position in IMGN in Q2 2022 and held it in 4 quarters. The position peaked at $205K in Q1 2023. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • Cornercap Investment Counsel reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 53,313 Immunogen Inc shares in Q2 2023, an estimated $205K.
  • Cornercap Investment Counsel first reported a position in Immunogen Inc in Q2 2022 and held it in 4 quarters.
  • Cornercap Investment Counsel's Immunogen Inc position peaked at $205K in Q1 2023.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Cornercap Investment Counsel's 13F filing for Q2 2023, filed 11 Aug 2023.